Press Releases

SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced strategic actions to reposition the Company with a focus solely on its ENHANZE® drug delivery technology. In order to implement this strategic shift, Halozyme will immediately initiate an organizational restructuring to halt development a

SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the HALO-301 Phase 3 clinical study evaluating investigational new drug PEGPH20 as a first-line therapy for treatment of patients with metastatic pancreas cancer failed to reach the primary endpoint of overall survival. The treatment arm of PEGPH20 in combinatio

SAN CLEMENTE, Calif., Nov. 4, 2019 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, announced today that it has entered into a definitive agreement to acquire Pursuit Vascular, Inc. for $75M with an a

LOS ANGELES, Nov. 4, 2019 /PRNewswire/ -- MAX BioPharma, Inc. (www.maxbiopharma.com) recently published two articles describing its anti-tumorigenic oxysterol lead compounds in

CHICAGO, Nov. 4, 2019 /PRNewswire/ -- The Alzheimer's Association and CVS Health announced today a three-year corporate partnership aimed at fighting Alzheimer's disease – a disease impacting more than 5 million Americans and 16 million caregivers across the country. The partnership is launching with an in-store fundraising campaign that will provid

NEW YORK, Nov. 4, 2019 /PRNewswire/ -- Elysium Health, Inc.,TM a life sciences company developing clinically validated health products based on aging research, today announced the launch of INDEX by Elysium Health, an at-home test that enables customers to measure their cumulative rate of aging and their biological age. The company also announced the addi

LAVAL, Quebec, Nov. 4, 2019 /PRNewswire/ --Third-Quarter 2019 Financial Results Revenues of $2.209 Billion GAAP Net Loss of $49 Million Adjusted EBITDA (non-GAAP)1 of $942 Million

DENVER, Nov. 4, 2019 /PRNewswire/ -- The recently announced Nephrology Care Alliance (NCA), a platform seeking to empower more physicians to succeed in integrated kidney care, is excited to be joined by Dr. Leslie Wong as its first chief medical officer. Chronic kidney disease (CKD) patients are a complex patient population and

NASHVILLE, Tenn., Nov. 4, 2019 /PRNewswire/ -- OneOncology leaders --

ORANGE COUNTY, Calif., Nov. 4, 2019 /PRNewswire/ -- Two kidney failure patients, together with two patient advocacy groups—the American Kidney Fund (AKF) and Dialysis Patient Citizens (DPC)—filed a federal lawsuit today in the U.S. District Court for the Central District of California against the